original ) (raw )Natriuretic peptide-guided levosimendan therapy for heart failure: A promising new approach
Andreas Kalogeropoulos
International Journal of Cardiology, 2008
View PDFchevron_right
Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
Marek Nalos
2003
View PDFchevron_right
Role of brain natriuretic peptide in the diagnosis and management of heart failure: Current concepts
Serge Masson , Inder Anand
Journal of Cardiac Failure, 2002
View PDFchevron_right
Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice
Les Toop
European Journal of Heart Failure, 2002
View PDFchevron_right
Brain Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide Show a Different Profile in Response to Acute Decompensated Heart Failure Treatment
Laura Magrini
Congestive Heart Failure, 2008
View PDFchevron_right
Brain Natriuretic Peptide: Structure, Action and Role in the Diagnosis and Prognosis of Heart Failure
Emmanuel Andreadis
Hospital chronicles, 2015
View PDFchevron_right
Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure
Mark Richards
Journal of the American College of Cardiology, 2006
View PDFchevron_right
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
Adam Ganz
The Lancet, 2000
View PDFchevron_right
Probrain Natriuretic Peptide for assessment of efficacy in heart failure treatment
Faruk Turgut
Advances in Therapy, 2007
View PDFchevron_right
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance
Zaid Abassi
Pharmacology & Therapeutics, 2004
View PDFchevron_right
Natriuretic peptides in heart failure]
Alberto Giannoni
2006
View PDFchevron_right
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin: A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
Finn Waagstein
2009
View PDFchevron_right
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial
Hans-Åke Persson
Circulation. Heart failure, 2011
View PDFchevron_right
Brain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure
Suman Bhandari
Indian journal of clinical biochemistry : IJCB, 2007
View PDFchevron_right
Urine measurement indicates the plasma brain natriuretic peptide concentration during optimization of heart failure treatment
Nana Waldréus
Scandinavian journal of clinical and laboratory investigation, 2015
View PDFchevron_right
The role of natriuretic peptides in heart failure
Giuseppe Limongelli
Current Cardiology Reports, 2008
View PDFchevron_right
Plasma Brain Natriuretic Peptide Levels Indicate the Distance From Decompensated Heart Failure * Response
Toshio Nishikimi
Circulation, 2004
View PDFchevron_right
A Study of the Correlation between Brain-type Natriuretic Peptide (BNP) Levels & Left Ventricular Ejection Fraction (LVEF) in Heart Failure
veena augustine , santhi silambanan
2016
View PDFchevron_right
Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure
Claudio Coletta , Silvia Perna
European Journal of Echocardiography, 2007
View PDFchevron_right
Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data
Nathalie Valli , Jean-benoît Corcuff
Clinica Chimica Acta, 2001
View PDFchevron_right
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
Serge Masson , Inder Anand
Circulation, 2003
View PDFchevron_right
Usefulness of Intermediate Amino-Terminal Pro-Brain Natriuretic Peptide Concentrations for Diagnosis and Prognosis of Acute Heart Failure
Mark Richards
The American Journal of Cardiology, 2006
View PDFchevron_right
Review on the Correlation between Natriuretic Peptide Levels and Heart Failure
IOSR Journals
View PDFchevron_right
Prognostic value of brain natriuretic peptide in acute heart failure: mortality and hospital readmission
Eduardo Nunez
Revista Española de …, 2008
View PDFchevron_right
Correlates and short-term prognostic value of plasma n-terminal pro-brain natriuretic peptide levels among heart failure patients: A prospective cohort study
Mark Mayala
2021
View PDFchevron_right
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin
John Kjekshus , John Wikstrand
Journal of the American College of Cardiology, 2009
View PDFchevron_right
Use of Brain Natriuretic Peptide and Bioimpedance to Guide Therapy in Heart Failure Patients
Roberto Valle
Contributions To Nephrology, 2010
View PDFchevron_right
Prognostic Impact of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure: A Substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial
Andrew Coats
Circulation, 2004
View PDFchevron_right